Immediate Loading of Bone Anchored Hearing Devices

Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT04611698
Collaborator
Northern Care Alliance NHS Foundation Trust (Other)
1
2
19

Study Details

Study Description

Brief Summary

Bone anchored hearing aids provide a hearing solution for patients that are unable to wear traditional air conduction hearing aid solutions. The technology of the devices has developed significantly over the last 510 years and patients are gaining access to their sound processor at a much earlier stage than when first brought onto the market. Despite this the investigators feel there is still room to develop this and with the new abutments with specialised hydroxyapatite coating it is hoped that patients can be loaded with their sound processor in the day of surgery. This study will compare abutment stability between two groups of patients. Those loaded immediately with their sound processor and those loaded traditionally at 2 weeks post operatively.

At routine followup appointments patients will have the stability of their abutment checked and the investigators will compare to see if loading earlier had any detrimental effects on osteointegration and the stability of the abutment.

Based on the favourable outcomes and high stability record for the BA400 it is anticipated that the time to processor fitting may be further reduced, provided favourable bone conditions at the implant site and provided satisfactory soft tissue status at the time of loading. It is hypothesised that loading immediately at the time of surgery is possible with comparable short and long term outcomes when compared to standard loading at 2 weeks

Condition or Disease Intervention/Treatment Phase
  • Device: Baha sound processor BA400
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Immediate Loading of Bone Anchored Hearing Devices
Actual Study Start Date :
Jun 1, 2016
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Dec 31, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate loading group

Visit 1 Implant surgery + Device loading Baseline Visit 2 Followup examination 2 weeks (2/+ 5 days) Visit 3 Followup examination 3 months (± 1 week) Visit 4 Followup examination 6 months (± 1 week) Visit 5 Followup examination 12 months (± 1 month)

Device: Baha sound processor BA400
Baha sound processor BA400 is a cochlear implant designed specifically for soft tissue preservation.

Experimental: 2-week loading group

Visit 1 Implant surgery Baseline Visit 2 Device loading 2 weeks (2/+5 days) Visit 3 Followup examination 3 months (± 1 week) Visit 4 Followup examination 6 months (± 1 week) Visit 5 Followup examination 12 months (± 1 month)

Device: Baha sound processor BA400
Baha sound processor BA400 is a cochlear implant designed specifically for soft tissue preservation.

Outcome Measures

Primary Outcome Measures

  1. Compare device stability and rate of successful implantation [12 months]

    Measuring device stability and rate of successful implantation for patients fitted with the Baha BA400 immediately on the day of surgery and at fitting 2 weeks post operatively. A successful implant is an implant that osseointegrates and is stable over time when supporting the load of the Baha sound processor.

Secondary Outcome Measures

  1. Measure the stability, as determined by Implant Stability Quotient (ISQ) values, of Baha implants placed immediately and at 23 weeks post operatively. [23 weeks]

  2. Record implant survival over time. [12 months]

  3. Monitor the status of the periimplant soft tissue using the classification proposed by Holgers' et al. [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients eligible for receiving the Baha system.
Exclusion Criteria:
  • Adult patients, i.e. ≥18 years

  • Eligible for the Baha system

  • Bone thickness at the implant site of at least 4 mm

  • No known disease or treatment that compromises / will compromise the bone quality at the implant site

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Manchester University NHS Foundation Trust
  • Northern Care Alliance NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04611698
Other Study ID Numbers:
  • R03963
First Posted:
Nov 2, 2020
Last Update Posted:
Nov 2, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2020